2023
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review
Jacobsen L, Sherr J, Considine E, Chen A, Peeling S, Hulsmans M, Charleer S, Urazbayeva M, Tosur M, Alamarie S, Redondo M, Hood K, Gottlieb P, Gillard P, Wong J, Hirsch I, Pratley R, Laffel L, Mathieu C. Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review. Communications Medicine 2023, 3: 132. PMID: 37794113, PMCID: PMC10550996, DOI: 10.1038/s43856-023-00358-x.Peer-Reviewed Original ResearchType 1 diabetesTreatment of peopleSystematic reviewAdvanced hybrid closed-loop systemBaseline glycemic levelsSelf-care burdenOptimization of outcomesContinuous glucose monitoring systemHybrid closed-loop systemAdvanced complicationsStandard careGlucose monitoring systemHypoglycemia riskGlycemic levelsGlycemic variabilityDiabetes therapyDiabetesHealthcare teamInsulin pumpType 1Glucose monitoringInsulin deliveryDevice initiationBehavioral modificationFurther studies
2021
Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation
Perkins BA, Sherr JL, Mathieu C. Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation. Science 2021, 373: 522-527. PMID: 34326234, DOI: 10.1126/science.abg4502.Peer-Reviewed Original ResearchConceptsInsulin therapySelf-care burdenSufficient glycemic controlType 1 diabetesRapid insulin analoguesInsulin delivery methodsInsulin delivery routeBroad clinical implementationMost patientsGlycemic controlGlycemic managementPharmacological advancesInsulin analoguesPharmacological solutionsInsulin pumpActivity monitorType 1Weight gainInsulin effectGlucose monitoringTherapyClinical implementationDelivery methodsInsulin moleculeKey metabolites